Scientific and Medical director and deputy General Manager of Fondation Mérieux
Marc Bonneville, D.V.M. and CNRS research director, is from July 2020 onwards the Scientific and Medical director and deputy General Manager of Fondation Mérieux.
Marc started to work in 1983 on transplantation immunology in Nantes (France), switched from 1987 to 1989 to analysis of mouse cellular immune responses during his postdoctoral training in S. Tonegawa’s laboratory (MIT, Boston). He became in 1990 the principal investigator of a research team within an INSERM unit in Nantes from 1990, and took over the direction of this unit in 1995, which became an INSERM Research Center that he led for more than 15 years.
In 2013, he was appointed as Chief Scientific and Medical Officer of the Institut Merieux, a biopharmaceutical holding that gathers companies developing diagnostic and therapeutic tools in the field of infectious diseases, cancer and food safety. Since 2016, he has been the chairman of the Alliance for Research and Innovation of Healthcare Industries (ARIIS). The purpose of this professional organization affiliated to the French Health Industry Federation (FEFIS) is to break down barriers in private research and promote synergies and partnerships between public research and industries in the field of pharmaceuticals, medical devices and diagnostics. While pursuing non-profit activities within the Institut Mérieux, in particular the Young Investigator Award program that he launched in 2016, Marc is now in charge of the scientific strategy of the Fondation Mérieux, and oversees its scientific and medical activities.
Marc has authored more than 200 scientific papers, is co-inventor of 8 patents, and is a co-founder of Innate Pharma SA, a biotech company that implements new immunotherapies targeting innate lymphocytes in infectiology and oncology. He has been involved in more than 30 national and international scientific advisory boards and evaluation committees. He has received the CNRS bronze and silver medals, and several prizes from charities (Fondation pour la Recherche Medicale, Ligue Nationale contre le Cancer, B. Halpern prize…) for his contributions on human cellular immunity in the context of infections and cancer.
cancer.